Tang-du Hospital
Clinical trials sponsored by Tang-du Hospital, explained in plain language.
-
New drug combo aims to shrink Hard-to-Treat breast tumors before surgery
Disease control Not yet recruitingThis study tests a two-step treatment for people with a common type of breast cancer (HR+/HER2-low) that has a higher risk of coming back. First, patients take a daily pill (dalpiciclib) plus a hormone blocker for about 4 months, then receive an IV drug (SHR-A1811) every 3 weeks …
Phase: PHASE2 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jun 16, 2026 23:19 UTC
-
Immunotherapy combo shows promise in battling esophageal cancer before surgery
Disease control Not yet recruitingThis study tests whether adding the immunotherapy drug toripalimab to standard chemotherapy before surgery can improve outcomes for people with resectable locally advanced esophageal squamous cell carcinoma. About 390 participants will be randomly assigned to receive either torip…
Phase: PHASE3 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
New drug duo aims to shrink throat tumors before surgery
Disease control Not yet recruitingThis study tests whether giving two drugs (vibecortamab and putilimab) before surgery can help shrink tumors in people with locally advanced laryngeal cancer. About 10 adults aged 18-80 with resectable cancer will receive the combination, then have surgery. The main goal is to se…
Phase: PHASE1, PHASE2 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
New drug combo shows promise in shrinking esophageal tumors before surgery
Disease control Not yet recruitingThis study tests whether adding a new drug called retlirafusp alfa to standard chemotherapy before surgery can help shrink tumors in people with a type of esophageal cancer. About 33 adults with locally advanced esophageal squamous cell carcinoma will receive the combination trea…
Phase: PHASE2 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jun 11, 2026 12:10 UTC
-
New drug combo aims to shrink lung tumors before surgery
Disease control Not yet recruitingThis study tests a new combination of two immunotherapy drugs (iparomlimab and tuvonralimab) given with chemotherapy before surgery for people with a specific type of advanced lung cancer (stage III-N2b). The goal is to see if this treatment can shrink or eliminate the tumor befo…
Phase: NA • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jun 10, 2026 13:25 UTC
-
Can a heart drug stop pneumonia after a stroke?
Prevention Not yet recruitingThis early study tests the safety of a 7-day intravenous drip of propranolol (a drug usually used for heart conditions) to prevent pneumonia in 30 adults who have had a severe brain bleed. The goal is to find the best dose and see if it reduces lung infections. Participants must …
Phase: PHASE1 • Sponsor: Tang-Du Hospital • Aim: Prevention
Last updated Jun 12, 2026 12:06 UTC
-
New anesthesia approach may speed recovery in lung cancer surgery
Symptom relief Not yet recruitingThis study compares two types of anesthesia for early-stage lung cancer surgery: one that lets patients breathe on their own and one that uses a breathing tube. Researchers want to see which method leads to a shorter hospital stay and less pain medication use. The study will incl…
Phase: NA • Sponsor: Tang-Du Hospital • Aim: Symptom relief
Last updated Jun 15, 2026 19:02 UTC
-
Coenzyme Q10 may boost IVF success in women with poor ovarian response
Symptom relief Not yet recruitingThis study tests whether taking coenzyme Q10 before IVF can improve egg quality and pregnancy outcomes in women who produce few eggs. About 128 women with poor ovarian response will be randomly assigned to receive Q10 or a placebo. The goal is to see if Q10 increases the number o…
Phase: NA • Sponsor: Tang-Du Hospital • Aim: Symptom relief
Last updated Jun 12, 2026 12:03 UTC
-
Blood test may predict best time for embryo transfer in IVF
Knowledge-focused Not yet recruitingThis study tests whether a blood test that measures tiny molecules called miRNAs can help predict the best time to transfer an embryo in women who have had multiple failed IVF attempts. About 546 women with unexplained recurrent implantation failure will be randomly assigned to h…
Phase: NA • Sponsor: Tang-Du Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 12:01 UTC